Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua D Courter

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Expert Review of Anti-Infective Therapy|December 5, 2008
Tipranavir: a new protease inhibitor for the pediatric populationJoshua D Courter, Jennifer E Girotto, Juan C Salazar
Hospital Pediatrics|April 26, 2018
Decreasing the Time to Insulin Administration for Hospitalized Patients With Cystic Fibrosis-Related DiabetesAllison Smego, Sarah Lawson, Joshua D Courter, et al.
Journal of the Pediatric Infectious Diseases Society|February 24, 2016
Pharmacodynamically Guided Levofloxacin Dosing for Pediatric Community-Acquired PneumoniaJoshua D Courter, Kristen R Nichols, Christina Kazazian, et al.
Pediatric Blood & Cancer|May 8, 2009
Optimizing bactericidal exposure for beta-lactams using prolonged and continuous infusions in the pediatric populationJoshua D Courter, Joseph L Kuti, Jennifer E Girotto, et al.
International Journal of Antimicrobial Agents|January 7, 2014
Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatricsKevin J Downes, Andrea Hahn, Jason Wiles, et al.
Therapeutics and Clinical Risk Management|October 20, 2010
Role of tipranavir in treatment of patients with multidrug-resistant HIVJoshua D Courter, Colleen J Teevan, Michael H Li, et al.
Transplantation and Cellular Therapy|December 7, 2021
Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation PatientsJulia C Gardner, Joshua D Courter, Christopher E Dandoy, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 29, 2024
Characterization of initial CLABSI culture results to support antimicrobial de-escalation in pediatric GI inpatientsMartina Beckman, Emily Firmenich, Conrad R Cole, et al.
Pediatrics|February 1, 2022
An Initiative to Reduce Insulin-Related Adverse Drug Events in a Children's HospitalSarah A Lawson, Lindsey N Hornung, Michelle Lawrence, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 25, 2022
Distinct Characteristics and Chronology of Amoxicillin-Associated Reactions in Pediatric Acute Care SettingsKatharine M Guarnieri, Susan S Xie, Joshua D Courter, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Expert Review of Anti-Infective Therapy|December 5, 2008
Tipranavir: a new protease inhibitor for the pediatric populationJoshua D Courter, Jennifer E Girotto, Juan C Salazar
Hospital Pediatrics|April 26, 2018
Decreasing the Time to Insulin Administration for Hospitalized Patients With Cystic Fibrosis-Related DiabetesAllison Smego, Sarah Lawson, Joshua D Courter, et al.
Journal of the Pediatric Infectious Diseases Society|February 24, 2016
Pharmacodynamically Guided Levofloxacin Dosing for Pediatric Community-Acquired PneumoniaJoshua D Courter, Kristen R Nichols, Christina Kazazian, et al.
Pediatric Blood & Cancer|May 8, 2009
Optimizing bactericidal exposure for beta-lactams using prolonged and continuous infusions in the pediatric populationJoshua D Courter, Joseph L Kuti, Jennifer E Girotto, et al.
International Journal of Antimicrobial Agents|January 7, 2014
Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatricsKevin J Downes, Andrea Hahn, Jason Wiles, et al.
Therapeutics and Clinical Risk Management|October 20, 2010
Role of tipranavir in treatment of patients with multidrug-resistant HIVJoshua D Courter, Colleen J Teevan, Michael H Li, et al.
Transplantation and Cellular Therapy|December 7, 2021
Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation PatientsJulia C Gardner, Joshua D Courter, Christopher E Dandoy, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 29, 2024
Characterization of initial CLABSI culture results to support antimicrobial de-escalation in pediatric GI inpatientsMartina Beckman, Emily Firmenich, Conrad R Cole, et al.
Pediatrics|February 1, 2022
An Initiative to Reduce Insulin-Related Adverse Drug Events in a Children's HospitalSarah A Lawson, Lindsey N Hornung, Michelle Lawrence, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 25, 2022
Distinct Characteristics and Chronology of Amoxicillin-Associated Reactions in Pediatric Acute Care SettingsKatharine M Guarnieri, Susan S Xie, Joshua D Courter, et al.
Pageof 4